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Neonatal calf diarrhoea remains the most common cause of morbidity and mortality in preweaned dairy calves
worldwide. This complex disease can be triggered by both infectious and non-infectious causes. The four most
important enteropathogens leading to neonatal dairy calf diarrhoea are Escherichia coli, rota- and coronavirus, and
Cryptosporidium parvum. Besides treating diarrhoeic neonatal dairy calves, the veterinarian is the most obvious
person to advise the dairy farmer on prevention and treatment of this disease. This review deals with prevention
and treatment of neonatal dairy calf diarrhoea focusing on the importance of a good colostrum management and
a correct fluid therapy.
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Neonatal calf diarrhoea (NCD), defined in this paper as
diarrhoea in calves aged 1-month-old or younger is a
complex disease that can be triggered by both infectious
and non-infectious causes. The prevalence and incidence
risk for NCD in dairy cattle herds has recently been
reported to be 19.1 and 21.2%, respectively [1,2]. In
calves aged <31 days, enteritis is the most common
cause of death with a case fatality risk for NCD of 4.9%
and a peak probability of dying due to enteritis during
the second week of life [1,3]. Enterotoxic Escherichia coli
K99/F5, rota- and coronavirus, and Cryptosporidium
spp. (≥85% C. parvum) are the 4 most important entero-
pathogens causing NCD worldwide with rotavirus and
C. parvum most frequently identified in faecal samples
from young calves [2,4-7]. Escherichia coli K99/F5 typically
causes diarrhoea in calves 1–4 days old and the other three
cause diarrhoea most often in 1 to 3-week-old calves.
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79.9%, 3.1-21.6% and 27.8-63.0%, respectively [2,5,7-12].
However, the enteropathogens most commonly impli-
cated in NCD outbreaks can also be found in faecal
samples from healthy calves, meaning that the presence
of a pathogen is not always causative [2,7]. Less common
enteropathogens causing NCD are Salmonella spp., attach-
ing and effacing E. coli among which enteropathogenic E.
coli, enterohemorrhagic E. coli and Shiga toxin producing
E. coli, Clostridium difficile, Clostridium perfringens, and
torovirus [2,13-16]. The veterinarian has an important
advisory role in the daily prevention and treatment chal-
lenge in practice. The aim of this review is therefore to
provide a critical analysis of recent literature on preven-
tion and treatment of NCD with emphasis on colostrum
management and fluid therapy.Search strategy and inclusion and exclusion
criteria for references
Web of Science (https://webofknowledge.com/) was
searched in September 2014 with ‘calf ’ AND ‘neonatal’
AND ‘diarrhoea’ AND ‘fluid therapy’ (46 references)
followed by ‘calf ’ AND ‘neonatal’ AND ‘diarrhoea’ AND
‘colostrum’ (136 references) as subject-specific terms.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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decade (2004-present) were considered to retain reliable
and recent advances on prevention and treatment of NCD
(93 references). Literature reviews and case reports were
not included but were scanned for missed references (190
references). Relevance screening was conducted by the
first author withholding only English papers dealing with
colostrum management or fluid therapy in conjunction
with neonatal diarrhoea in dairy calves (105 references).
There were no publication status restrictions.
Review
Prevention
Dairy farms with a confirmed NCD diagnosis should
consult a veterinarian. Together they should go through
the herd anamnesis addressing the young stock manage-
ment creating a list with possible critical control points.
Key questions in this anamnesis are: colostrum manage-
ment, housing and hygiene, feeding of the calves, possible
periods of stress, drugs used, and prevention of immuno-
modulating infectious diseases (e.g. bovine viral diarrhoea
virus or infectious bovine rhinotracheitis virus).
Colostrum management is the most important pre-
ventive measure that should be addressed and this will
be discussed in further detail later in this review.
In view of the increasing pressure in the veterinary
field to lower the use of antimicrobials (AB), using AB
as a prophylactic or metaphylactic measure is debatable.
Metaphylactic use of AB can only be recommended for
a short period on herds actively struggling with E. coli
diarrhoea problems. Furthermore, calves receiving pro-
phylactic AB in their milk for the first 2 weeks of life have
a 28% greater risk for diarrhoea compared with calves
receiving no prophylactic AB in their milk [17].
In a Swedish study in 2010 disinfection of single pens
between calves was more common in herds suffering
from NCD when compared to herds without problems
[7]. This can be explained by herds starting with disin-
fecting procedures if suffering from NCD. Single pens
should be disinfected before moving any new calf and
not only when an outbreak of NCD occurs.
The control of C. parvum can only be achieved by
combining a good hygiene management and effective
preventive drugs [18-20]. Newborn calves should not be
mixed with older calves since the age of the calf is an
important risk factor for shedding of C. parvum oocysts
[18,21-23]. In Europe, halofuginone lactate is the only
registered product for prevention and treatment of C.
parvum. Different studies find a delayed and lower
oocyst output peak the first 2 weeks after birth in halo-
fuginone treated groups as compared to placebo groups
[21,24-27].
Calves born to dams vaccinated against E. coli, rotavirus
and coronavirus also shed less C. parvum oocysts [6]. Thislower shedding of C. parvum oocyst is most likely a reflec-
tion of a generally higher standard of herd management
in these herds, rather than a direct protective effect. A
vaccine against C. parvum has not been developed yet.
The literature is contradictory or inconclusive concern-
ing ancillary preventive products such as phytopharma-
ceuticals (e.g. clinoptilitezeolite) and probiotics (e.g. E. coli
Nissle 1917) [28-30]. The herd veterinarian is advised
to consult results of peer-reviewed controlled trials for
separate products.
Colostrum management
Although the importance of a good colostrum management
leading to an adequate passive transfer is undebatable in
the prevention of NCD [17,31-33], there are studies show-
ing no significant effect of colostrum feeding routines on
the risk of diarrhoea or on the risk of shedding C. parvum
[4,6]. This lack of a significant effect can be explained by a
high number of diarrhoea cases caused by C. parvum, for
which colostral IgG is less protective [6]. An FPT preva-
lence <10% is considered as a rational and achievable goal
when using a cut-off value of 10 g IgG/l [34]. However,
several studies proposed serum IgG concentrations up
to 15 g/l as cut-off points for defining failure of passive
transfer (FPT) [1,35,36]. Percentages of FPT range from
8.4 to >90.5% depending on the cut-off value, the popu-
lation studied, and/or the method used to estimate calf
serum IgG levels [1,12,17,37-39]. The odds of FPT are
higher when there is no on-farm routine screening [38];
therefore, IgG concentration of 48-hours-old calves should
be estimated regularly to test the compliance of the colos-
trum management and is most practical in the field by
determining serum total protein using a refractometer.
Colostrum also contains other beneficial constituents in
higher concentrations than normal milk: immunologically
active leukocytes, fat, protein, fat-soluble vitamins (e.g.
retinol, tocopherol, β-carotene), water-soluble vitamins
(e.g. niacin, thiamine, riboflavin, vitamin B12, pyridoxal,
pyridoxamine, pyridoxine), minerals (e.g. Ca, P, Mg, Na,
K, Zn, Fe, Cu, S, Mn) and, non-specific antimicrobial
factors (e.g. lactoferrin) [40].
The functional importance of colostral leukocytes is
not yet fully understood. Some studies show that they
enhance lymphocyte responses to nonspecific mitogens
and specific antigens and increase antigen-presenting
capacity [41-44], while others suggest that the role of
fresh colostral leukocytes may not be as important as
once thought [45]. As protection against C. parvum is
mainly cell-mediated, further research into the import-
ance of colostral leukocytes is warranted.
Colostrum quality
IgG concentration Colostral IgG concentration is an
important factor that affects whether calves receive
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nately, the amount of IgG in maternal colostrum varies
dramatically among cows (<1-235 g/l) with 29.4-57.8% of
samples that do not reach the desired amount of 50 g
IgG/l [34,47-49]. Colostral quality is difficult to estimate
by the farmer based on produced volume or appearance
of the colostrum. Use of weight at first milking as a
screening test to identify bovine colostrum with inad-
equate IgG concentration is not justified because of the
low sensitivity [50]. Somatic cell count, measured after
calving, was significantly higher in cows producing colos-
trum of inferior quality compared with those producing
high-quality colostrum [47]. For all these reasons, it is
better to measure colostral IgG content indirectly by using
a colostrometer (50 g IgG/l = density of 1045) or a brix
refractometer (50 g IgG/l =21-22 Brix) or directly by a
cow-side immunoassay kit (single line = IgG concen-
tration >50 g IgG/l [50-53]. To measure colostrum quality
it should be avoided to use forestripping samples for test-
ing purposes, as these samples may overestimate the IgG
concentration [54]. Colostrum collected more than 2 hours
after calving significantly lowers the colostral IgG con-
centration [55,56], probably because of dilutional effects
and because colostral Ig diffuse passively into the cow’s
systemic circulation if colostrum is not milked out as soon
as possible after calving. Colostrum from cows without a
dry period has a lower IgG concentration compared with
colostrum from cows having a dry period of 28 or 56 days
[57]. Pooling of colostrum is not advised since this is a risk
factor for FPT [38]. Cows in their 3rd or 4th parity or older
usually have significantly higher levels of IgG per liter
colostrum than heifers or 2nd parity cows [34,47,48] which
is reflected in calves born to heifers having a greater
risk for FPT than calves born to multiparous cows [32].
However, this correlation between parity and colostrum
IgG concentration is not always evident [36]. Discarding
colostrum from heifers is thus not advisable.
Colostrum replacement products have a highly variable
performance [49,58-65], and the herd veterinarian is
advised to consult results of peer-reviewed controlled
trials for separate products. Colostrum supplemented
in milk replacer during the first 2 weeks of life (10 g
IgG, bid) reduces NCD rates because of the intestinal
activity of colostral antibodies and epithelial growth
promoting substances [66].
Bacteriological quality Critical control points for bacter-
ial contamination of colostrum are the harvest and storage
process. Storing colostrum at ambient temperatures re-
sults in a significant increase of bacteria [67]. Fresh colos-
trum can be stored up to 96 hours at 4°C when potassium
sorbate is added as a preservative [67]. Industry recom-
mendations for bacterial load are limited to 100,000
colony forming units (cfu)/ml. Depending on the time ofsampling or used storage method, 0-43% of colostrum
samples exceed the maximum advised bacterial count of
100,000 cfu/ml [48,67].
Pasteurizing colostrum (60°C, 60 min) can reduce
bacterial load while the viscosity and the colostral IgG
concentration remain within acceptable limits for feeding
[68-72]. Higher-quality batches of colostrum suffer a sig-
nificantly greater magnitude of loss of IgG as compared
with lower- or intermediate- quality batches of colostrum
[68,71]. Calves fed pasteurized colostrum had significantly
higher serum IgG concentrations, serum protein values,
and/or a greater apparent efficiency of absorption, com-
pared with calves fed unpasteurized colostrum [46,72-75],
probably explained by bacteria that bind free IgG in the
gut lumen and block uptake and transport of IgG mole-
cules across intestinal epithelial cells. Moreover, calves fed
pasteurized colostrum had a significantly decreased risk
for treatment for diarrhoea [46].
Colostrum feeding practices
Calves allowed to nurse their dam have higher odds of
FPT than calves separated from their dam within 3 hours
of birth [37,38]. When allowed to nurse, calves drink too
late and too little colostrum. Feeding calves as much col-
ostrum as they want by nipple bottle within 1–4 hours
after birth and at 12 hours of age substantially reduces
the probability of FPT [34,37,76]. Bottle fed calves that
do not ingest colostrum voluntarily, should be tube fed
[34,76]. Feeding at least 150 to 200 g of colostral IgG is
required for adequate passive transfer of colostral IgG
when colostrum is administered once by oesophageal
intubation <2 hours after birth [36]. To estimate the
exact amount of IgG given to a calf, colostrum quality
should be measured as explained higher: if colostrum
contains 50 g IgG/L, feeding 4 L of colostrum suffices to
provide 200 g IgG to the calf. There is no added benefit
in feeding 4 L of colostrum compared to 3 L when
colostrum of comparable quality is fed once using an
oesophageal tube [77]. Larger IgG intakes are required
by calves being fed >2 hours after birth [36]. Hand feeding
colostrum >4 hours after birth is a risk factor for FPT
[38]. A slight delay in the increase of serum Ig concen-
tration was obvious in calves receiving 4 L of colostrum
by oesophageal intubation compared with bottle-fed
calves receiving 2 L. However, calves receiving colostrum
by oesophageal intubation reached significantly higher
Ig concentrations compared with bottle-fed calves [78].
Because of the difference in administered volume (4 L
versus 2 L) between the two methods (oesophageal
intubation versus bottle-fed), it can only be concluded
from this study that an appropriate use of an oesophageal
tube to feed 4 L colostrum is a safe and reliable method
for an adequate passive immune transfer in healthy new-
born calves. This study does not prove colostrum fed by
Table 1 Guide to assessing the degree of acidosis based
on posture, behaviour and palpebral reflex of the calf
(adapted from [85])
Category BE (mmol/l)
Posture Calf standing up by itself −2.2
Calf standing up after encouragement 0.0
Standing steadily after lifting 2.8
Standing unsteadily, able to correct
position if forced
−11.7
Standing unsteadily, unable to correct
position if forced
−20.6
Unable to stand, sternal recumbency −20.9
Unable to stand, lateral recumbency −25.4
Behaviour Adequate reaction to acoustic and
optical stimuli, very bright and alert
2.5
Adequate reaction to acoustic and
optical stimuli
1.8
Delayed reaction to acoustic and
optical stimuli
−14.6
Calf reacts only to painful stimuli −21.0
No reaction to painful stimuli −25.4
Palpebral
reflex
Eyelids are closed immediately and fully 0.7
Eyelids are closed immediately but
not fully
−7.6
Eyelids are closed with delay and not fully −19.9
Eyelids are not closed at all −24.3
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colostrum. Further research is needed to reveal if the rapid
passage of Ig from the reticulorumen to the abomasum
also occurs in weak born calves. Moreover, tube feeding
can cause moderate depression or a more difficult adapta-
tion to feeding with a nipple bucket [78].
Calves cared for by female workers are less likely to
develop FPT [37], probably because women are more
patient with newborn calves that refuse to suckle. The
odds of FPT are higher for calves experiencing dystocia
[32] which can be explained by drinking too little colos-
trum and/or a lower apparent efficiency of absorption.
Treatment
Fluid therapy
Diarrhoea leads to dehydration, acidosis, electrolyte
imbalance, and hypoglycemia, all of which should be
addressed by a well-executed fluid therapy manage-
ment [31,79,80].
Metabolic acidosis in diarrhoeic calves arises not only
from fecal bicarbonate loss and hyper-L-lactatemia, but
mainly from a hyper-D-lactatemia. Hyper-L-lactatemia is
a result of dehydration and decreased tissue perfusion.
Hyper-D-lactatemia is caused by absorption of D-lactic
acid produced in the gastro-intestinal tract by fermenta-
tion of malabsorbed carbohydrates [81,82]. Variations in
behaviour, posture and palpebral reflex are more closely
correlated with elevations of serum D-lactate concentra-
tions than with decreases in base excess (BE) [79,83,84].
However, BE values can be estimated based on posture,
behaviour, and palpebral reflex (Table 1) with calves
aged ≥7 days having lower BE values than younger calves
[31,84,85]. Impairment of a good sucking reflex is more
related to the degree of dehydration than it reflects acid-
osis [79,83,86]. There is even no obvious correlation
between the serum levels of D-lactate and dehydration
[82]. Remarkably, ability to stand was maintained in quite
some calves despite BE values below −20 mmol/l, demon-
strating the risk of undercorrection when based on this
ability [85].
High potassium levels are more closely correlated to
dehydration than to parameters indicative of metabolic
acidosis [87,88]. Therefore, K+ levels should be decreased
to normal by correction of the acidosis and hypoglycaemia
but more importantly by improving tissue perfusion.
Oral rehydration therapy Administration of an oral re-
hydration solution (ORS) should be commenced as soon
as diarrhoea starts and should be continued as long as
the calf has diarrhoea.
The osmolality of an ORS is determined primarily by
the concentrations of sodium and glucose. Calves fed
hyperosmotic ORS solutions (600–717 mOsm/l) (HORS)
have a slower abomasal emptying rate compared withcalves fed iso-osmotic ORS solutions (300–360 mOsm/l)
(IORS). This slower emptying rate increases the risk for
bloat or abomasitis and produces a slower rate of plasma
volume expansion [80,89,90]. Unless previously assumed,
the volume present in the reticulorumen of healthy calves
after intubation appears to be predominantly due to reflux
from the abomasum, rather than spillage from incomplete
closure of the oesophageal groove. The calculated change
in abomasal volume of intubated calves approximated that
one of calves that suckled their ORS [80]. In contrast,
the delivery of HORS to the small intestine is slower
after intubation indicating a different effect of intubation
on coordinating motility between the reticulorumen,
abomasum and duodenum than does suckling [80].
These effects taken together, suckling an IORS provides
the fastest rate of solution delivery to the small intestine
and a slightly faster rate of plasma volume expansion than
does suckling or oesophageal intubation of a HORS.
However, suckling or oesophageal intubation of a HORS
provides the most appropriate oral solution for treating
hypoglycaemic calves, because the HORS produces a
larger and more sustained increase in plasma glucose
concentration [80].
Alkalinizing agents commonly used in commercial
ORS are bicarbonate and bicarbonate precursors, mainly
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assumed alkalinisation of ORS products containing
bicarbonate (BORS) or citrate (CORS) when compared
to solutions containing other bicarbonate precursors is
confirmed by most recent studies in absolute numbers,
but never significantly different [90-93]. High SID-fluids
(≥79 mmol/l) are recommended to treat acidosis because
the SID value of an ORS determines the degree of
abomasal and serum alkalinisation [91,94]. Prolongation
of the in vivo clotting time is more likely to occur when
larger volumes of an ORS in cow’s milk are fed, because
luminal pH will initially be greater and remain greater
for a longer period of time [90,95]. From these studies it
can be carefully concluded that feeding a BORS or
CORS does not affect milk clotting in vivo and disagrees
with general recommendations to not feed BORS or
CORS concurrently with or short before/after cow’s milk
to calves. The SID value and fed amount of an ORS
seem to play a more important role, both in correcting
dehydration and metabolic acidosis [91,94].
It should be noted that most of the research discussed
above was executed in a small number of healthy,
non-diarrhoeic calves. Milk clotting, abomasal luminal
pH and abomasal emptying rates could differ between
diarrhoeic and non-diarrhoeic calves.
Intravenous fluid therapy Intravenous (IV) fluid ther-
apy should be implemented if the calf is severely dehy-
drated (>8%), depressed, has a weakened/absent suckle
reflex or suffers from a dilated abomasum and/or intes-
tinal hypomotility. The fluids should always be warmed
e.g. by adding a coil to the IV fluid line and placing this
in a bucket of hot water so that the calf does not need
to use extra energy to bring the given fluid to body
temperature. To sustain improved clinical status, an IV
fluid therapy needs to be followed by continued ORS ther-
apy [31,96]. Both the jugular as the auricular veins can be
catheterized for IV rehydration, but by using the ear vein,
larger quantities of fluid can be given during a longer
period of time in an on farm setting.
Bicarbonate requirements for IV correction of acidosis
are still being calculated as follows: bicarbonate (g) = body
weight (kg) × BE (mmol/l) × 0.6 (l/kg) × 0.084 (g/mmol)
[86,96]. When using this formula, metabolic acidosis was
not corrected in more than half of the calves and the
risk of failure to correct acidosis increased with D-lactate
concentrations [86]. Calves with distinct changes in
posture and demeanour thus seem to need higher doses
of bicarbonate than calculated with the factor of 0.6 in
the formula mentioned. However, in this study no
follow-up therapy with ORS was offered, which could
explain calves becoming acidotic again after 24 h. Other
studies reporting treatment failures had a more severe
metabolic acidosis before treatment compared withsuccessfully treated calves [31,96]. The formula mentioned
above should only be used for estimation of buffer
required for correction of incurred losses and overdosing
seems more desirable than underdosing [86]. Bicarbonate
can be given IV as an isotonic (IBS) or hypertonic solution
(HBS). In the field it is more practical to use a HBS
compared with an IBS. Rapid IV administration of an
8.4% bicarbonate formulation at 5–10 ml/kg provided
an effective and safe method to improve acid–base
abnormalities [31,96-98]. There were no direct indica-
tions in these studies of potential adverse effects related
to electrolyte concentrations, oxygen-haemoglobin dis-
sociation curve, hypercapnia or paradoxical intracellular
acidosis, as previously assumed. It can be concluded from
these studies that HBS can be safely used if the speed of
an IV administration does not exceed 1.25 ml/kg/min in
calves not suffering from respiratory problems.
Hypoglycaemia is best addressed by giving 150 mg
glucose/kg. Larger quantities of glucose should be avoided
because of the risk of glycosuria. Calves that are cachectic
and reluctant to drink can also be given a constant glucose
infusion using the ear vein approach as discussed earlier.
Other important treatment measures
Routine use of AB in diarrhoeic calves cannot be recom-
mended due to increased levels of antibiotic resistance.
However, systemically ill calves (depression, anorexia,
fever) often suffer from E. coli septicaemia and thus paren-
teral Gram-negative-spectrum AB are advised to treat
these calves. Antimicrobial susceptibility testing methods
should be performed on the herd level at a regular basis
[99,100]. As mentioned, halofuginone lactate is the only
registered product for prevention and treatment of C.
parvum in Europe. In 2009 a meta-analysis for the effects
of therapeutic halofuginone treatment was conducted
[21]. Their results were considered as uninterpretable be-
cause of a lack of sufficient data. Azithromycin (1,500 mg/
d, 7 days, per oral (PO) and lasalocid (8 mg/kg, sid, 3 days,
PO) reduce oocyst shedding [101,102]. Therapeutic use
of nitazoxanide (15 mg/kg, bid, PO, 10 days) did not
improve the clinical appearance, nor the intensity of
oocyst excretion [103]. In contrast, calves of the thera-
peutic group showed a longer diarrhoeic episode com-
pared to the untreated control group. Antiviral drugs to
treat rota- and coronavirus are not commercially avail-
able. Non-steroidal anti-inflammatory drugs (NSAID) like
meloxicam (0.5 mg/kg, one-shot, SC) improve appetite
and growth rate, probably because NCD is accompanied
by malaise and gastrointestinal discomfort [39]. Despite
their widespread use, there is no valid recent research
available to recommend products reducing intestinal
motility (e.g. hyoscine N-butylbromide).
The literature is contradictory or inconclusive concerning
other ancillary treatments such as phytopharmaceuticals
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having diarrhoea, severity of diarrhoea and mortality rates
were similar between an oral treatment with neomycin or
dried oregano leaves [105]. However, a negative control
group receiving no treatment was not included and they
also defined calves older than 4 days with diarrhoea to
suffer from colibacillosis. Lactobacillus rhamnosus GG did
not affect the outcome of therapy in diarrhoeic calves
[104]. The herd veterinarian is advised to consult results
of peer-reviewed controlled trials for separate products.
Overall, the herd veterinarian should focus on the
prevention of NCD.
Conclusions
Neonatal calf diarrhoea is a complex disease with a high
morbidity and mortality in dairy cattle herds. Colostrum
management is the most important preventive measure
but is often neglected. Also, in the therapy management
a good fluid therapy is indispensable. However, mistakes
are often made. The herd veterinarian should be up-to-
date when it comes to prevention and therapy of NCD.
He or she is the most obvious person to communicate
these items to the dairy farmer.
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